Archives

by in
Entry Author Date Location
Bill Gates, Yuri Milner Join $13.5M Round For Foundation Medicine 01/08/13 Boston
Amgen in $180.5 Million Drug Development Deal with BIND Biosciences 01/08/13 Boston
My Report Card for JP Morgan Healthcare Conference Picks 01/07/13 National
SD Life Sciences Roundup: Organovo, Aethlon, & Deals, Deals, Deals 01/04/13 San Diego
Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target 01/03/13 San Diego
Oncothyreon Cancer Drug Fails in Final Trial; Shares Tank 12/19/12 Seattle
Blend Therapeutics Raises $16 Million to Fund Cancer Drug Development 12/18/12 Boston
After Strikeout, San Diego’s MEI Pharma Looks to Rebuild Confidence 12/17/12 San Diego
2012: The Year When Genomic Medicine Started Paying Off 12/17/12 National
FDA Approves Ariad Leukemia Drug Three Months Ahead of Schedule 12/14/12 Boston
San Diego Life Sciences Roundup: Acadia, Zogenix, Isis, & More 12/14/12 San Diego
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
San Diego Life Sciences Roundup: Optimer, Volcano, Avelas Bio, & More 12/07/12 San Diego
Avelas Bio Raises $7.65M to Advance Fluorescing Diagnostic for Cancer 12/06/12 San Diego
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
Epic Sciences Raises $13M, Advances Ultra-Sensitive Cell Diagnostics 11/13/12 San Diego
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
San Diego’s Ambit Biosciences Raises $25M to Advance Leukemia Drug 11/06/12 San Diego
San Diego Life Sciences Roundup: Shire, Thesan, ViaCyte, and More 11/02/12 San Diego
Aveo Cuts Staff, Announces 3rd Quarter Loss 10/31/12 Boston
Seattle Genetics, Millennium Cancer Drug Cleared in EU 10/31/12 Seattle
San Diego Life Sciences Roundup: Accelrys, AirStrip, Ligand, & More 10/25/12 San Diego
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
E. Donnall Thomas, Bone Marrow Transplant Pioneer at the Hutch, Dies at 92 10/21/12 Seattle
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More 10/05/12 San Diego
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Genentech, ImmunoGen Souped-Up Breast Cancer Drug Extends Lives 10/01/12 San Francisco
Bayer, Onyx Cancer Drug Wins FDA Approval Ahead of Schedule 09/27/12 San Francisco
Page 4 of 49 « previous page · next page »